Flare Therapeutics Launches with $82 Million Series A Financing to Advance Precision Oncology Pipeline based on Novel Drug Discovery Approach for Transcription Factors

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3hqRIRg
via IFTTT